IGF1 and hepatocellular carcinoma: In hepatocellular carcinoma, anoikis resistance of hepatoma cells has been determined to require PAK1 activity,23 and CAV1 could also confer resistance of hepatoma cells to anoikis by activating the IGF‐1 pathway.24